- news
- Multimédia
Multimédia
Photos
Vidéos
-
pharma.be meets Jean Stephénne
-
Découvrez les gagnants du Prix Galien 2019
-
pharma.be annual Clinical Trials Forum 2019
-
Le secteur (bio)pharmaceutique en Belgique : coeur battant de l'économie de la connaissance. Catherine Rutten commente les chiffres du secteur
-
Round table "Innovation in pharma" 2019
-
Lara Bloom nous parle du syndrome d'Ehlers-Danlos
-
Innovation drives the pharma sector. Discover here Biotech company working on 3D innovative bone cell therapy.
-
Innovation drives the pharma sector. Discover here a Biotech working on innovative cell liver therapy.
-
Discover here a short movie about the pharma.be Dialogue 2018 dedicated to cell & gene therapy.
-
Innovation drives the pharma sector. Discover here a Biotech company working on Car T against cancer.
-
Innovation drives the pharma sector. Discover an innovative cell therapy for bones reconstruction.
-
pharma.be meets Dr Emmanuel Hanon, Senior Vice-President and Head of R&D, Global Vaccines GSK, on importance of vaccination.
-
Les traitements innovants sont le résultat d'années de passion, d'expertise et de dévouement pour les individus. Les employés du secteur biopharmaceutique belge témoignent de leur engagement à aider les patients.
-
-
-
Jean-Georges Compère participated to a clinical trial. He speaks about his patient experience.
-
Kristel De Gauquier - Medical Director pharma.be : " Les maladies rares sont un défi pour l'industrie pharmaceutique"
-
Vidéo de la campagne d'information #LeCombatContinue
-
Catherine Rutten, CEO pharma.be, explique la campagne d'information #LeCombatContinue
-
Clinical Trial Forum Part II - Interviews with Catherine Rutten (CEO pharma.be), Liesbeth Moortgat (AS Delta), PR. Sylvie Rottey (UZ Ghent).
-
Clinical Trial Forum - Part I - Interviews with Catherine Rutten (CEO pharma.be), Jean-Pierre Latere (Celyad), PR. François Duhoux (UCL St Luc)
-
Compilation movie - pharma.be Dialogue 2017
-
Dialogue 2017: interview with Manuella Wilts. Director costumer services EMEA Johnson&Johnson
-
Dialogue 2017: interview with Herman De Croo. Minister of State
-
Dialogue 2017: interview with Sonja Willems. Chairwoman pharma.be.
-
Dialogue 2017: interview with Dirk Lannoo. V.P. Katoen Natie.
-
Dialogue 2017: interview with Gert Bervoets. CEO ESSERS.
-
Dialogue 2017: interview with Pascale Delcomminette. CEO Wallonia Foreign Trade and Investment Agency (AWEX)
-
Dialogue 2017: interview Catherine Rutten. CEO pharma.be.
-
N-SIDE: bringing forecasting, simulation & optimization solutions to pharma
-
Lieven Zwaenepoel (APB): Digital innovation in community pharmacies
-
Federal Agency inspections for quality and safe medicines (famhp)
-
The journey of a medicine: from production to delivery to patients
-
Dr. Isabelle Huyghe, Senior Clinical Research physician at Pfizer, describing the importance of clinical trials and volunteering.
-
Mario, a clinical trial volunteer, about his motivations to participate to a clinical trial study.
-
Anna Colzi, Medical Director at Pfizer's phase 1 unit at the Erasmus hospital in Brussels, is describing the patients" engagement to clinical trials.
-
50 years of pharma.be Symposium (compilation)
-
"New perspectives in Hepatitis C treatment" - Véronique Scaillon
-
"Improved quality of life of Psoriasis patients" - Paul De Corte
-
"Innovations give hope to pancreatic cancer patients" - Leo Coene
-
"How HIV became a treatable, chronic disease" - Patrick Reyntiens
-
Xavier De Cuyper (famhp) : "Preserving the Belgian leadership in clinical trials in Europe"
-
Facts & figures on the Belgian Pharma Valley
-
Belgium's contribution to therapeutic innovation through the past decades
-
Proud to be part of pharma : Francis' role within Zoetis, is development and production of new vaccines for animals. Follow on Twitter: #pharmafaces
-
"Proud to be part of pharma" : Tom (AbbVie) looks to develop new,innovative solutions to support patients with chronic diseases in their treatment process. Follow on Twitter: #pharmafaces
-
"Proud to be part of pharma" : After a five-year career as a general practitioner, Dr. Paul Lacante made the switch to the pharmaceutical industry and is now Medical Director. Follow on Twitter: #pharmafaces
-
"Proud to be part of pharma" : Ingrid (UCB) works closely with a team of MSL's that gives scientific support to physicians. Follow on Twitter : #pharmafaces
-
Nathan De Valck works for the Brussels Airport Company in the Cargo Management team. Brussels Airport stands out for its dedicated infrastructure to transport medicines. Follow on Twitter : #pharmafaces
-
"Proud to be part of pharma" : Alain-Geert works in the production department of Genzyme, a biotech company that is part of Sanofi. Follow on Twitter : #pharmafaces
-
"Proud to be part of pharma" : Ellen is a Customer Service Representative at Pfizer. Her objective is to deliver innovative medicines as quick as possible to patients in need, worldwide. Follow on Twitter : #pharmafaces
-
"Proud to be part of pharma" : As a Market Access Manager for GSK, Catheline acts after a medicine has been registered. She is responsible for submitting applications for price & reimbursement. Follow on Twitter : #pharmafaces
-
"Proud to be part of pharma" : Working as a Regulatory Affairs Manager for the pharmaceutical company MSD Belgium, Laurence is responsible for the approval process of the registration of new medicines. follow on Twitter : #pharmafaces
-
"Proud to be part of pharma" : Anne-Sophie is a Clinical Research Associate (CRA) for the pharmaceutical company Novo Nordisk. Her main task is to start up, follow up and close clinical trials. follow on Twitter : #pharmafaces
-
"Proud to be part of pharma" : Ole works for Janssen Pharmaceutica in Belgium, as a Principal Research Scientist in the R&D group. His expertise lies mainly in the world of personalised pharmaceutical development. Follow on Twitter : #pharmafaces
-
Catherine Rutten, CEO pharma.be - speech at Dialogue @pharma.be 2016
-
Interview with Sjaak De Boer (Cordaid) at the Dialogue @pharma.be 2016
-
Interview with Prof. dr. Marleen Temmerman at the Dialogue @pharma.be 2016
-
Interview with Eduardo Pisani @ the Dialogue @pharma.be 2016
-
Interview with Jaak Peeters (J&J) at the Dialogue @pharma.be 2016
-
Sonja Willems, Chairwoman of the Board of pharma.be - speech at the Dialogue @pharma.be 2016
-
Dialogue @pharma.be 2016 (produced by Mevipro)
-
Luc Debruyne, President & General Manager of GSK Vaccines - speech at the Dialogue @pharma.be 2016
-
Interview with An-Heleen De Greef, Philanthropy Manager, Doctors of the World Belgium
-
Interview with Sam Proesmans, Doctor in Internal Medicine
-
Interview with Dr Adrian Hopkins, Director Mectizan Donation Program
-
Interview with Dr Dirk Teuwen, VP Corporate Societal Responsibility, UCB
-
Interview with Michael Leniere, Project Lead Supply Chain Pfizer
-
Interview with Dr Dirk D'Hooge , Medical Director Novo Nordisk Pharma
-
2015 IFPMA Pharma By Numbers
-
EFPIA: What Is The Innovative Medicines Initiative? (IMI)
-
LEEM: Pourquoi participer à un essai clinique ?
-
EFPIA: Transparency and Privacy
-
EFPIA: Clinical Trials and Transparency
-
EFPIA: The importance of Clinical Trials
-
EFPIA: Designing a Clinical Trial
-
EFPIA: The Journey of Clinical Trials
-
IFPMA video on awareness of fake medicines
-
Le 11 juin 2015, les Mutualités Libres (MLOZ) ont organisé un débat sur 'des médicaments à tout prix?'. Au cours de ce débat, Catherine Rutten, CEO de pharma.be, a souligné les coûts de développement élevés d'un médicament avant la mise sur le marché et les prix bas des médicaments en Belgique par rapport à d'autres pays en Europe.
-
EFPIA video: Intellectual Property & the Pharma Industry - Introducing Marty the Medicine
-
Catherine Rutten: « Conserver la pole position dans la recherche clinique »
-
Catherine Rutten: « Amener les médicaments plus rapidement sur le marché »
-
Catherine Rutten (pharma.be): « Le débat sur le prix des médicaments doit être élargi »
-
Observance thérapeutique et bon usage des médicaments